ArticleCancer chemotherapy and pharmacology2014

Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS.

Tomokazu Kishiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.